A 3-year study of in vitro activity of new antifungal agents against Candida isolates causing candidaemias

A. Stylianakis*, V. Papaioannou, S. Tsiplakou, P. Thomaidis, K. Tsopelas, D. Argyris, S. Mantzari, K. Mouta

Author address: 

Athens, GR)

Abstract: 

Objectives: to evaluate the in vitro antifungal activity of caspofungin (CSF), anidulafungin (ANG), micafungin (MCF) and posaconazoletarget genes via MSE. In addition, the importance of the R432 residue suggests a novel approach to design new antifungal drugs through screening compounds blocking the interaction between Ndt80p and its targets.
2012

abstract No: 

P839

Full conference title: 

22nd European Congress of Clinical Microbiology and Infectious Diseases
    • ECCMID 22nd (2012)